We suggested that, following bleomycin‐induced ALI, nintedanib therapy can ameliorate high tidal volume mechanical stretch‐augmented EMT and pulmonary fibrosis by suppressing the Src pathway. This evidence concerns the gene SRC and acute respiratory distress syndrome.